Volume 18, Number 7—July 2012
Ebola Virus Antibodies in Fruit Bats, Ghana, West Africa
To the Editor: Fruit bats are the presumptive reservoir hosts of Ebola viruses (EBOVs) (genus Ebolavirus, family Filoviridae). When transmitted to humans and nonhuman primates, EBOVs can cause hemorrhagic fevers with high case-fatality rates. In 2008, we detected Zaire EBOV (ZEBOV) antibodies in a single migratory fruit bat (Eidolon helvum) from a roost in Accra, Ghana (1). This bat is common in sub-Saharan Africa and lives in large colonies, often in cities. The flight of an individual E. helvum bat during migration has been recorded as >2,500 km (2).
To understand whether the single seropositive Eidolon helvum bat was evidence of EBOV circulation in the Greater Accra Region or elsewhere in sub-Saharan Africa, we tested serum of 88 nonmigratory fruit bats from the surrounding region of Ghana. Serum samples had been collected, as previously described (3,4), during May–June 2007 from fruit bats in woodland and tropical forest habitats in southern Ghana within 180 km of Accra. Initial screening for EBOV antibodies was conducted by using ELISA with a 1:1 mixture of recombinant nucleoprotein (NP) of ZEBOV and Reston EBOV (REBOV). Proteins were expressed in an Escherichia coli expression vector with a polyhistadine tag (1,5). Samples with optical density (OD) readings 3-fold above the mean OD of 2 negative control serum samples were considered EBOV-positive by ELISA. ELISA-positive samples were tested separately (at a dilution of 1:50) for reactivity against ZEBOV and REBOV NPs by using ELISA and Western blot (WB) as described (1). Each sample with positive results from both assays was retested at increasing dilutions to determine the highest dilution (endpoint titer) at which it remained positive (>3-fold above the OD for EBOV-negative sera).
We detected EBOV antibodies (1:1 mixture of both NP antigens, OD>0.7) in serum samples from 32 of 88 bats (10/27 Epomops franqueti, 14/37 Epomophorus gambianus, 7/16 Hypsignathus monstrosus, 1/4 Nanonycteris veldkampii, and 0/1 Epomops buettikoferi). When tested against an individual NP, 13 of the 32 EBOV-positive serum samples were positive for EBOV (OD >0.50). Of those 13 EBOV-positive samples, 9 were ZEBOV-positive only (from 3 E. franqueti, 4 E. gambianus, and 2 H. monstrosus bats), 3 were REBOV-positive only (from 2 E. gambianus and 1 H. monstrosus bats), and 1 sample from an E. gambianus bat was positive for both ZEBOV and REBOV. Seven samples that the EBOV NP ELISA identified as positive were also positive by WB (Table). Each WB-positive serum sample was positive for the EBOV antigen that it had been most reactive against in the ELISA: 5 WB test results were positive for ZEBOV (2 of those samples also bound to REBOV), and 2 bound to REBOV only. Serum samples with positive OD values at endpoint dilutions >1:50 were definitively positive by WB; whereas those with positive OD values at and endpoint dilution of 1:50 only could be positive, negative, or equivocal by WB (Table).
Previous serum and viral antigen tests indicated the presence of EBOV among 2 of these bat species (E. franqueti and H. monstrosus) in Gabon, located in central Africa (6). Two others (E. gambianus and N. veldkampii) were not previously identified as potential reservoirs. Because these are nonmigratory fruit bats, our findings demonstrate that at least 1 serotype of EBOV circulates in bats in the Upper Guinean forest ecosystem in West Africa. These data might provide evidence that Taï Forest EBOV (TEBOV), formerly known as Côte d’Ivoire EBOV, circulates in this ecosystem among bats native to West Africa (7). EBOV antibody titers are highly correlated (8), but using TEBOV antigen might increase seroprevalence if TEBOV is the circulating virus. However, geographic location does not necessarily determine EBOV genetic relationships (9), and lack of cross-reactivity between serum samples positive for REBOV and ZEBOV in our study might indicate that divergent viruses circulate regionally, given phylogenetic and antigenic relationships between EBOV species (7–10).
We detected a relatively high proportion of EBOV-seropositive fruit bats in a relatively small sample size of mixed species. We suggest that the prevalence of EBOV in these tested bat species is greater than that previously detected in E. helvum bats (1/262 serum samples) (1). The higher estimated prevalence in these species occurred despite the fact that E. helvum bats live in large colonies comprising several million animals, which make the species an ideal host for acute RNA virus infections. The relatively low seroprevalence of EBOV among E. helvum bats compared with that among sympatric species is contrary to our findings for a lyssavirus and an uncharacterized henipavirus (3,4). Our results, therefore, lead us to question what factors (e.g., host, ecologic) limit EBOV circulation in straw-colored fruit bats. Virus isolation is required to characterize EBOVs circulating among fruit bats in Ghana, and additional testing, including longitudinal sampling of bats, is required to further investigate the epidemiology of EBOV in West Africa. Possible public health threats should also be investigated and addressed. These initial findings, however, suggest that the risk for human infection with EBOV might be greater from bat-human contact in rural and forest settings than from urban-roosting E. helvum bats.
We thank the Wildlife Division of the Forestry Commission, Ghana, and the Veterinary Services Directorate for their continued support for this study, and 2 anonymous reviewers for their comments.
This study was funded by the Wellcome Trust (to D.T.S.H.), UK Department for Environment, Food and Rural Affairs (grant VT0105), and the Research and Policy for Infectious Disease Dynamics program (RAPIDD [managed by the US Department of Homeland Security and the Fogarty International Center, National Institutes of Health]). A.A.C. is supported by a Royal Society Wolfson Research Merit award.
- Hayman DTS, Emmerich P, Yu M, Wang LF, Suu-Ire R, Fooks AR, Long-term survival of an urban fruit bat seropositive for Ebola and Lagos bat viruses. PLoS ONE. 2010;5:e11978.
- Richter HV, Cumming GS. First application of satellite telemetry to track African straw-coloured fruit bat migration. J Zool (Lond). 2008;275:172–6.
- Hayman DTS, Fooks AR, Horton DL, Suu-Ire R, Breed AC, Wood JL, Antibodies against Lagos bat virus in megachiroptera in West Africa. Emerg Infect Dis. 2008;14:926–8.
- Hayman DTS, Suu-Ire R, Breed AC, McEachern JA, Wang L, Wood JL, Evidence of henipavirus infection in West African fruit bats. PLoS ONE. 2008;3:e2739.
- Marsh GA, Haining J, Robinson R, Foord A, Yamada M, Barr JA, Ebola Reston virus infection of pigs: clinical significance and transmission potential. J Infect Dis. 2011;204(Suppl 3):S804–9.
- Leroy EM, Kumulungui B, Pourrut X, Rouquet P, Hassanin A, Yaba P, Fruit bats as reservoirs of Ebola virus. Nature. 2005;438:575–6.
- Le Guenno B, Formenty P, Wyers M, Gounon P, Walker F, Boesch C. Isolation and partial characterisation of a new strain of Ebola virus. Lancet. 1995;345:1271–4.
- Ksiazek TG, West CP, Rollin PE, Jahrling PB, Peters PB. ELISA for the detection of antibodies of antibodies to Ebola viruses. J Infect Dis. 1999;179(Suppl 1):S192–8.
- Towner JS, Sealy TK, Khristova ML, Albariño CG, Conlan S, Reeder SA, Newly discovered Ebola virus associated with hemorrhagic fever outbreak in Uganda. PLoS Pathog. 2008;4:e1000212.
- Negredo A, Palacios G, Vázquez-Morón S, González F, Dopazo H, Molero F, Discovery of an Ebolavirus-like filovirus in Europe. PLoS Pathog. 2011;7:e1002304.
- Table. ZEBOV- and REBOV-specific results of ELISA and Western blot analysis of serum from Ebola virus–positive fruit bats, Ghana
Suggested citation for this article: Hayman DTS, Yu M, Crameri G, Wang L-F, Suu-Ire R, Wood JLN, et al. Ebola virus antibodies in fruit bats, Ghana, West Africa [letter]. Emerg Infect Dis [serial on the Internet]. 2012 Jul [date cited]. http://dx.doi.org/10.3201/eid1807.111654
Please use the form below to submit correspondence to the authors or contact them at the following address:
David T.S. Hayman, University of Cambridge, Madingley Rd, Cambridge, CB3 0ES, UK
Comment submitted successfully, thank you for your feedback.
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
- Page created: June 14, 2012
- Page last updated: June 14, 2012
- Page last reviewed: June 14, 2012
- Centers for Disease Control and Prevention,
National Center for Emerging and Zoonotic Infectious Diseases (NCEZID)
Office of the Director (OD)